COVID-19

Ethanol has demonstrated high efficacy in inactivating enveloped viruses in vitro and in vivo (in animal and human studies). The inhalation route has been a significant method of drug administration for respiratory disorders since ancient times.

Both the global prevalence of diabetes and the frequency of natural and man-made disasters are increasing. Of all chronic diseases, the consequences of sudden loss of medical supplies are most serious for those with diabetes, with people living …

Lower respiratory tract infections caused by SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) cause a significant disease burden globally, despite the availability of effective vaccines. Certain populations, such as older adults (≥ 60 …

Acute respiratory tract infections (ARIs) are major causes of morbidity and mortality worldwide [ 1 ]. Defined as infectious diseases of the respiratory tract, ARIs can be caused by a variety of viral or bacterial pathogens [ 2 ]. ARIs can be …

The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) came with much higher transmissibility compared to previous variants, leading to rapid increases in case numbers globally [ 1 , 2 ]. It also poses a significant …

Ethanol has demonstrated high efficacy in inactivating enveloped viruses in vitro and in vivo (in animal and human studies). The inhalation route has been a significant method of drug administration for respiratory disorders since ancient times.

To quantify the value of non-marketed goods and services such as health care interventions, health economic evaluations often seek to elicit the maximum amount that individuals are willing to pay for them. This amount can then be used to estimate …

COVID-19-related pneumonia can trigger a hyperinflammatory response, marked by elevated levels of cytokines, such as interleukin-6 (IL-6). [ 1 , 2 ]. This so-called cytokine storm has been associated with worse clinical outcomes, including acute …